Adagio gets $336m funding to advance antibody treatment for Covid-19
Adagio will use the funding to advance its lead candidate ADG20, a single agent intended for both treatment…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Apr 21
Adagio will use the funding to advance its lead candidate ADG20, a single agent intended for both treatment…
Active Pharmaceutical Ingredients and IntermediatesPharmaceuticals
20 Apr 21
The EC approval is based on the Phase 3 IKEMA study, which showed that Sarclisa plus standard of…
19 Apr 21
AstraZeneca has initially announced the acquisition of the US-based pharmaceutical firm for a total consideration of $39bn in…
19 Apr 21
The FDA approval is based on CheckMate-649, a Phase 3 trial evaluating Opdivo in combination with chemotherapy
16 Apr 21
The business combination would add highly complementary services that further enhance Thermo Fisher’s value proposition for pharma and…
16 Apr 21
Novartis will dedicate its large-scale biologics facility in Singapore for the production of API of Roche’s Actemra/RoActemra
15 Apr 21
The Chinese regulatory approval is based on positive results from the Phase 3 ADAURA trial, which enrolled 682…
15 Apr 21
The EC approval is based on results from the CheckMate -9ER an open-label, randomised, Phase 3 clinical trial…
14 Apr 21
The company has partnered with the Russian Direct Investment Fund (RDIF) in September last year for clinical trials…
14 Apr 21
CDC and FDA are reviewing data comprising six cases of a rare and severe type of blood clot…